T. Rowe Price Investment Management Portfolio holdings
T. Rowe Price Investment Management, Inc. (TRPIM), a division of T. Rowe Price Group established in August 2022 and headquartered in Baltimore, Maryland, is an active investment manager overseeing hundreds of billions in assets, focusing on equity and fixed-income strategies for institutional clients and sub-advisory mandates. Spun off from the parent company founded in 1937 by Thomas Rowe Price, Jr., TRPIM operates as a distinct entity with around 900 employees, emphasizing a research-driven, long-term approach rooted in fundamental analysis and disciplined risk management. Managing portfolios like large-cap growth and international equity funds, it complements T. Rowe Price’s broader offerings while targeting sophisticated investors such as pension funds and endowments with tailored, high-conviction solutions. Under the leadership of president Rob Sharps, TRPIM upholds the firm’s legacy of integrity and client focus, adapting its founder’s value-oriented philosophy to modern institutional needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$784M |
| 2 |
Danaher
DHR
|
+$764M |
| 3 |
Intuit
INTU
|
+$679M |
| 4 |
PTC
PTC
|
+$559M |
| 5 |
Avantor
AVTR
|
+$447M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CrowdStrike
CRWD
|
+$766M |
| 2 |
Spotify
SPOT
|
+$730M |
| 3 |
KKR & Co
KKR
|
+$587M |
| 4 |
Goldman Sachs
GS
|
+$531M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$515M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.38% |
| 2 | Healthcare | 20.33% |
| 3 | Industrials | 12.32% |
| 4 | Consumer Discretionary | 11.88% |
| 5 | Financials | 10.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BFS
376
Saul Centers
BFS
$860M
| $54.1M | 0.03% |
1,472,376
-357,812
| -20% | -$13.1M |
|
377
Kilroy Realty
KRC
$4.3B
| $53.9M | 0.03% |
1,729,984
+82,322
| +5% | +$2.73M |
|
378
LCI Industries
LCII
$2.6B
| $53.6M | 0.03% |
518,765
-44,219
| -8% | -$4.77M |
|
|
PRA
379
DELISTED
ProAssurance
PRA
| $53.4M | 0.03% |
4,372,256
+205,295
| +5% | +$2.79M |
|
380
Quaker Houghton
KWR
$2.95B
| $52.9M | 0.03% |
311,746
-241,309
| -44% | -$44.6M |
|
381
Viavi Solutions
VIAV
$10.6B
| $52.7M | 0.03% |
7,669,683
+1,565,596
| +26% | +$12.2M |
|
382
Floor & Decor
FND
$6.3B
| $52.3M | 0.03% |
526,325
-98,626
| -16% | -$11.3M |
|
383
PRA Group
PRAA
$774M
| $52.2M | 0.03% |
2,657,194
+294
| +0% | +$6.76K |
|
384
RenaissanceRe
RNR
$13.3B
| $51.5M | 0.03% |
230,575
+21,354
| +10% | +$4.78M |
|
385
Old Dominion Freight Line
ODFL
$45.1B
| $51.2M | 0.03% |
289,793
+97,722
| +51% | +$18.4M |
|
|
HLVX
386
DELISTED
HilleVax
HLVX
| $50.3M | 0.03% |
3,481,222
+419,518
| +14% | +$5.76M |
|
387
Neumora Therapeutics
NMRA
$328M
| $50.1M | 0.03% |
5,101,096
+1,517,092
| +42% | +$15.7M |
|
388
Doximity
DOCS
$4.5B
| $49.8M | 0.03% |
+1,779,805
| New | +$46.9M |
|
389
Black Diamond Therapeutics
BDTX
$118M
| $49.7M | 0.03% |
10,659,730
+3,934,365
| +59% | +$21.1M |
|
|
FBMS
390
DELISTED
The First Bancshares, Inc.
FBMS
| $49M | 0.03% |
1,887,796
-303,716
| -14% | -$7.48M |
|
391
Cathay General Bancorp
CATY
$4.31B
| $48.7M | 0.03% |
1,290,904
+73,462
| +6% | +$2.66M |
|
392
Equity Bancshares
EQBK
$1.06B
| $48.4M | 0.03% |
1,374,034
-31,640
| -2% | -$1.06M |
|
393
International Paper
IP
$21.7B
| $47.1M | 0.03% |
+1,091,546
| New | +$44.3M |
|
394
Warby Parker
WRBY
$3.22B
| $47.1M | 0.03% |
2,932,408
-1,125,577
| -28% | -$16.6M |
|
395
Immunome
IMNM
$3.03B
| $46.9M | 0.03% |
3,878,595
+2,362,141
| +156% | +$37M |
|
396
Certara
CERT
$1.23B
| $46.5M | 0.03% |
3,354,430
+152,132
| +5% | +$2.5M |
|
397
Matsons
MATX
$6.44B
| $46.4M | 0.03% |
354,490
+4,491
| +1% | +$522K |
|
398
Nurix Therapeutics
NRIX
$2.8B
| $45.7M | 0.03% |
+2,189,192
| New | +$34.1M |
|
399
Encore Capital Group
ECPG
$2.14B
| $45.4M | 0.03% |
1,087,679
-24,916
| -2% | -$1.07M |
|
400
Manhattan Associates
MANH
$11.3B
| $45.2M | 0.03% |
183,344
-188,099
| -51% | -$42.7M |
|
Similar funds
T. Rowe Price Investment Management's Q2 2024 Portfolio in Review
As of Q2 2024, T. Rowe Price Investment Management held 668 positions worth $158B, down 3.1% from $163B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
T. Rowe Price Investment Management's Q2 2024 filing shows 48 new, 292 increased, 275 reduced and 48 closed positions. Its largest new stake was Broadcom: 5,594,890 shares worth $898M. The largest sale was CrowdStrike, an estimated $766M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Industrials.
- T. Rowe Price Investment Management's largest Q2 2024 buy was Broadcom: 5,594,890 shares worth $898M.
- T. Rowe Price Investment Management added most to Danaher in Q2 2024, an estimated $764M increase.
- T. Rowe Price Investment Management's biggest Q2 2024 reduction was CrowdStrike, cutting an estimated $766M.
- T. Rowe Price Investment Management fully exited CATALENT, INC. in Q2 2024, selling an estimated $231M.
- T. Rowe Price Investment Management's ten largest holdings make up 17% of its $158B portfolio in Q2 2024.
- T. Rowe Price Investment Management opened 48 new positions and closed 48 in Q2 2024.
- T. Rowe Price Investment Management's portfolio value fell 3.1% quarter-over-quarter to $158B.
Based on T. Rowe Price Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.